Starling Medical · Aug 2025
Introduces Pete, a coming-soon product extension focused on daily wellness and longevity.
AI enabling digital urine diagnostics in the home
Public company, workplace, funding, and market signals
Updated Jul 29, 2026
Starling Medical is a Houston-based digital health / medical-device company building UrinDx, a toilet-installed at-home urine monitoring platform for recurring UTI and broader urinary-health remote monitoring, sold through provider partnerships and insurance reimbursement.
Primary product
UrinDx™
Founded
2019
Headquarters
2450 Holcombe Blvd, Suite 1320, Houston, TX 77021
Team size
10-20
Work style
Onsite
Industry
Medical Device / Digital Health
Sub-industry
At-home urinalysis / remote patient monitoring
Offices
0 jobs at Starling
Check back later for new openings
Business model
Stage
Series A
Total raised
$20.8M
Latest round
Series A - II · Mar 2026
Latest amount
$820K
Mar 2026
Jun 2025 · MedTech Innovator
Dec 2024
Oct 2024 · HLTH Startup Pitch Competition
Sep 2024 · Pixel Perfect Ventures
Jan 2023 · Rebel Fund
Leadership
Founder & CEO
Founder & Clinical Strategist
Principal Data Scientist
Lead Product Engineer
Daniel Saldaña
VP of Manufacturing
Investors
Mission-driven team focused on proactive, predictive home-based care; the company describes a mix of serial entrepreneurs, engineers, and clinicians and emphasizes preventing hospitalizations.
Work style
Onsite
Visa sponsorship
No
Compensation
Public job posts showed salary bands of $70K-$90K and $85K-$115K, plus 0.25%-0.50% equity, with roles limited to US citizen/visa holders.
Benefits
Pricing
Insurance-reimbursed RPM; users often pay $0, while practices are billed a flat monthly fee for monitoring and coaching.
Differentiators
Technology
Customers
Competitors
Estimated revenue
under $1M (public estimates vary; some databases show $1-5M)
Estimated monthly visits
1.7K
Traffic estimate as of Jun 2026
Starling Medical · Aug 2025
Introduces Pete, a coming-soon product extension focused on daily wellness and longevity.
Starling Medical · Aug 2025
Explains Pete as a daily check product aimed at peace of mind and aging-related monitoring.
Starling Medical · Aug 2025
Positions Pete as a tool to help break the cycle of recurring UTIs.
CATALYST by Wellstar · Oct 2024
Conference-related coverage tied to Starling Medical’s presence in the healthcare innovation ecosystem.
CATALYST by Wellstar · Oct 2024
Announced Catalyst by Wellstar’s investment in Starling Medical and positioned the company as a remote monitoring / predictive algorithm startup.